Since CD44-targeted NIR-PIT showed an effective therapeutic response in a MOC2-luc tumor, we analyzed the tumor infiltration of CD8+ T cells before and after CD44-targeted NIR-PIT. This evidence concerns the gene CD44 and neoplasm.